Our landscape report provides a high-level overview of the Part B program and offers clients a comprehensive review of key Part B dynamics to aid in accurately assessing brand-related opportunities and threats in the multifaceted Part B market. Our report includes 7 Part B modules and 2 bonus modules on the following topic areas: Part D Overview, Benefit Design, Drug Access, Reimbursement, Biosimilar Market, Legislative Trends, Inflation Reduction Act, 340 B Market Dynamics and Clinical Care Pathways.